Literature DB >> 57015

beta 2-microglogulin levels in cancerous and other disease states.

J Shuster, P Gold, M D Poulik.   

Abstract

Serum beta2-microglobulin levels were measured, by radioimmunoassay, in patients suffering from a variety of benign and malignant clinical disorders. Elevated beta 2-microglobulin values were found in neoplastic and non-neoplastic disorders affecting a variety of organs. The most striking increases in beta 2-microglobulin are found in the plasma cell dyscrazias and several solid tumors, particularly those affecting the lung. Lymphoid neoplasms demonstrate a spectrum of changes of serum beta 2-microglobulin. At the one end of this spectrum were the plasma cell tumors, which show a high incidence of raised beta 2-microglobulin levels, while patients with Hodgkin's disease rarely show such increases in circulating beta 2-microglobulin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 57015     DOI: 10.1016/0009-8981(76)90339-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  24 in total

1.  β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells.

Authors:  Sajni Josson; Takeo Nomura; Jen-Tai Lin; Wen-Chin Huang; Daqing Wu; Haiyen E Zhau; Majd Zayzafoon; M Neale Weizmann; Murali Gururajan; Leland W K Chung
Journal:  Cancer Res       Date:  2011-03-22       Impact factor: 12.701

2.  Serum thymidine kinase in diagnosis and follow-up of the small cell carcinoma of the lung.

Authors:  V Abbasciano; L Graziano; D Arcudi; G Felisatti; A R Cavallini; M G Reali; N Calia; S Campi; C Guglielmini
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

3.  Circulating Beta-2 Microglobulin and Risk of Cancer: The Atherosclerosis Risk in Communities Study (ARIC).

Authors:  Anna E Prizment; Amy M Linabery; Pamela L Lutsey; Elizabeth Selvin; Heather H Nelson; Aaron R Folsom; Timothy R Church; Charles G Drake; Elizabeth A Platz; Corinne Joshu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02-05       Impact factor: 4.254

4.  Beta 2-microglobulinaemia: a sensitive index of diminishing renal function in diabetics.

Authors:  G C Viberti; H Keen; D Mackintosh
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-10

5.  Serum beta 2 microglobulin in adult myeloid acute leukemias.

Authors:  L Campos; H Vu Van; D Ville; C Imbert; O Gentilhomme; Y C Luo; D Fiere; J J Viala
Journal:  Blut       Date:  1984-04

6.  Prevalence of anti-beta-2 microglobulin autoantibodies in sera of rheumatoid arthritis patients with extra-articular manifestations.

Authors:  A Falus; K Merétey; S Bozsóky
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

7.  Serum beta 2-microglobulin and C reactive protein concentrations in viral infections.

Authors:  E H Cooper; M A Forbes; M H Hambling
Journal:  J Clin Pathol       Date:  1984-10       Impact factor: 3.411

8.  Genetic and clinical studies of serum beta 2-microglobulin levels in haematological malignancies.

Authors:  Y Nakao; H Matsumoto; T Miyazaki; S Watanabe; T Masaoka; K Takatsuki; M Kishihara; N Kobayashi; M Hattori; T Fujita
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

9.  The cerebrospinal fluid and plasma concentrations of gamma-trace and beta2-microglobulin at various ages and in neurological disorders.

Authors:  H Löfberg; A O Grubb; T Sveger; J E Olsson
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

10.  Plasma levels of beta 2-microglobulin in rheumatoid arthritis.

Authors:  K G Sjöblom; T Saxne; F A Wollheim
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.